Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
BBI Solutions
BBI Solutions
Activities:
Ingredients
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Ingredients
BBI Solutions completes reagent manufacturer acquisition
BioTeZ is a manufacturer of reagents and finished tests for the in-vitro diagnostics (IVD) market
Finance
BBI creates new jobs to support next phase in COVID-19 home test development
The lateral flow antibody test that can be used by people in their homes to determine if they have an antibody response to COVID-19
Research & Development
BBI Solutions partners to distribute COVID-19 antigens in China
The Native Antigen Company has agreed distribution rights with BBI to provide coronavirus reagents in China
Ingredients
BBI Solutions expands infectious disease reagent suite
BBI Solutions has demonstrated internal antibody development capabilities and has also expanded its infectious disease reagent suite
BBI Solutions increases capacity for transferrin production
BBI Solutions (BBI) has invested in its facilities and resources to increase the capacity of cell culture native human transferrin production by up to 40%
Subscribe now